Ticker Symbol: IKT
Inhibikase Therapeutics Inc
$1.93 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001750149
Company Profile
Inhibikase is a clinical-stage pharmaceutical company developing therapeutics for Parkinson's disease and related disorders that arise inside and outside of the brain. Inhibikase is headquartered in Atlanta, Georgia with additional offices in Boston, Massachusetts.
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: 3350 Riverwood Pkwy SE Ste 1927
Website: www.inhibikase.com
CEO: N/A
Tags:
- Health Technology
- Pharmaceuticals: Major
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $0.94
Change:
$0.01
(
2.10%)
Days Range: $0.85 - $0.96
Beta: 0.09
52wk. High: $6.94
52wk. Low: $0.79
Ytd. Change -66.52%
50 Day Moving Average: $1.35
200 Day Moving Average: $2.75
Shares Outstanding: 5348326
Valuation
Market Cap: 503.4M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A